SynthesisFrontiers in cardiovascular medicine2026
Effects and exercise-prescription moderators of Tai Chi on cardiometabolic risk factors in middle-aged and older women: a systematic review and meta-analysis.
Synthesis in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cardiometabolic risk increases substantially in middle-aged and older women, particularly during and after the menopausal transition. Tai Chi is a low-to-moderate intensity mind-body exercise that may offer an accessible non-pharmacological strategy for cardiometabolic risk management. However, women-specific evidence and the role of exercise-prescription characteristics remain unclear. This systematic review and meta-analysis evaluated the effects of Tai Chi on cardiometabolic risk factors in middle-aged and older women and examined whether effects varied by baseline health status, comparator type, and intervention dose. Methods: PubMed, Web of Science, the Cochrane Library, Embase, and CNKI were searched from inception to September 2025 for randomized controlled trials of structured Tai Chi programmes in women aged 45 years or older. Cardiometabolic outcomes were pooled using random-effects models, with moderator, sensitivity, publication bias, and GRADE analyses conducted where appropriate. Results: Eighteen randomized controlled trials were included. Tai Chi was associated with significant reductions in systolic blood pressure, diastolic blood pressure, LDL-C, triglycerides, and total cholesterol, whereas no clear effects were observed for HDL-C or fasting blood glucose. However, heterogeneity was substantial for most significant outcomes, and prediction intervals generally crossed the null, indicating that effect magnitude and consistency may vary considerably across future comparable settings. Pulse wave velocity was summarized narratively because only two studies reported this outcome and measurement sites differed. Subgroup analyses suggested that baseline health status, comparator type, and intervention duration might partly explain heterogeneity, although these analyses were exploratory. Discussion: Tai Chi may improve selected cardiometabolic outcomes in middle-aged and older women, particularly blood pressure and atherogenic lipid markers. However, the certainty and generalizability of these findings remain limited. Larger trials using standardized Tai Chi prescriptions and consistent outcome measures are needed. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251146060, PROSPERO, CRD420251146060.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.